Lv2
126 积分 2025-04-28 加入
Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L)1 inhibitor strategies
1天前
待确认
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2天前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
1个月前
已完结
Screening, expression, and functional validation of camelid-derived nanobodies targeting RSPO2
1个月前
已完结
2,3-Difunctionalized Indoles via Radical Acylation or Trifluoromethylation of ortho-Alkynylphenyl Isonitriles
1个月前
已完结
The therapeutic antibody sacituzumab induces trophoblast cell-surface antigen-2 conformational rearrangement
1个月前
已完结
Off-target reactivity in clinical monoclonal antibodies
1个月前
已完结
The tumor microenvironment’s role in the response to immune checkpoint blockade
2个月前
已完结
Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses
2个月前
已完结
Trop2, Nectin-4, and PD-L1 expression profiles in esophageal squamous cell carcinoma: Implications for combined immunotherapy and ADC targeted therapies
2个月前
已完结
皖公网安备34019202002308
